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SUMMARY
TRPM7 is a ubiquitous ion channel and kinase, a unique ''chanzyme,'' required for proper early embryonic development. It conducts Zn 2+ , Mg 2+ , and Ca
2+
as well as monovalent cations and contains a functional serine/threonine kinase at its carboxyl terminus. Here, we show that in normal tissues and cell lines, the kinase is proteolytically cleaved from the channel domain in a cell-type-specific manner. These TRPM7 cleaved kinase fragments (M7CKs) translocate to the nucleus and bind multiple components of chromatin-remodeling complexes, including Polycomb group proteins. In the nucleus, the kinase phosphorylates specific serines/threonines of histones. M7CK-dependent phosphorylation of H3Ser10 at promoters of TRPM7-dependent genes correlates with their activity. We also demonstrate that cytosolic free [Zn 2+ ] is TRPM7 dependent and regulates M7CK binding to transcription factors containing zinc-finger domains. These findings suggest that TRPM7-mediated modulation of intracellular Zn 2+ concentration couples ion-channel signaling to epigenetic chromatin covalent modifications that affect gene expression patterns.
INTRODUCTION
TRPM7 is a ubiquitously expressed cationic ion channel and serine/threonine kinase (Nadler et al., 2001; Runnels et al., 2001; Yamaguchi et al., 2001) . Global disruption of Trpm7 in mice results in embryonic lethality before embryonic day 7 (E7) (Jin et al., 2008) . Tissue-specific reduction of TRPM7 gene expression between E7 and E12 of development results in abnormalities of multiple organs (Jin et al., 2012) . TRPM7-deficient thymocytes exhibit dysregulated synthesis of many growth factors that are necessary for the differentiation and maintenance of thymic epithelial cells (Jin et al., 2008) . Loss of TRPM7 at an intermediate developmental time point alters the myocardial transcriptional profile in adulthood, impairing ventricular function (Sah et al., 2013) . TRPM7 overexpression in human embryonic kidney cells alters the transcriptional profile of hundreds genes (Lee et al., 2011) . These data indicate that TRPM7 is intimately associated with developmental, tissue-specific regulation of gene activity. We set out to determine how TRPM7's channel or kinase function has such broad, tissuespecific, and age-dependent effects on gene activity.
Initially, TRPM7 was thought to mediate cellular Mg 2+ homeostasis based on growth arrest in TRPM7-deficient DT-40 B cells: growth arrest could be restored by culturing these cells in media supplemented with high Mg 2+ (Nadler et al., 2001; Schmitz et al., 2003 Schmitz et al., , 2005 . In other cell types, however, loss of TRPM7 expression resulted in defects in cell growth that could not be rescued by excess Mg 2+ (Hanano et al., 2004) or that even promoted proliferation (Inoue and Xiong, 2009 ). In addition, TRPM7 was not essential for proliferation and maintenance of Mg 2+ levels in thymocytes derived from mice with a tissue-targeted TrpM7 deletion (Jin et al., 2008) . In some cases, TRPM7 appears to modulate Ca 2+ signaling (Du et al., 2010; Hanano et al., 2004; Middelbeek et al., 2012) . Thus, the consequences of TRPM7's channel function are not settled; it may vary by tissue type and/or by its relative localization and gating in the cell's plasma or intracellular membranes.
TRPM7's most unique aspect is its C-terminal active serine/ threonine kinase. The functional significance of this coupling of channel and kinase is not clear. Aside from the hypothesis that channel-dependent changes in cytosolic Mg 2+ may control the activity of the kinase (Schmitz et al., 2003) , no experimental data suggest that kinase activity is channel dependent. In turn, kinase activity is not essential for channel gating (Clark et al., 2006; Matsushita et al., 2005) , although it may modulate channel activity (Demeuse et al., 2006; Desai et al., 2012; Schmitz et al., 2003) . Although TRPM7 kinase activity may be controlled through the autophosphorylation of a serine/threonine-rich region located N terminal to the catalytic domain (Clark et al., 2008b) , external signals regulating the kinase activity are not known. In vitro substrates for the TRPM7 kinase, annexin A1 and myosin IIA heavy chain (Clark et al., 2008a) , are not necessarily substrates in vivo.
More recently, the TRPM7 kinase was proposed to regulate phosphorylation of eukaryotic elongation factor 2 (eEF2) via activation of the eEF2-kinase (Perraud et al., 2011) . Here, we show that in many cell lines and normal tissues, TRPM7's kinase is released from the channel domain in a cell-type-specific fashion. TRPM7 cleaved kinases (M7CKs) translocate to the nucleus and bind multiple components of chromatin-remodeling complexes, including Polycomb group proteins. In the nucleus, TRPM7's kinase modifies specific histone phosphorylation, particularly in the promoters of TRPM7-dependent genes. We show that cytosolic free zinc levels are TRPM7 dependent and regulate M7CK binding to transcription factors containing zinc-binding domains. We hypothesize that TRPM7-mediated increases in cytoplasmic zinc couples channel function to chromatin covalent modification and thus affects cellular differentiation and embryonic development.
RESULTS
The TRPM7 Kinase Is Proteolytically Cleaved from the Channel Domain In Vivo Although ubiquitously expressed, TRPM7 protein is of low abundance. In order to detect endogenous protein expression, we isolated the protein from large numbers of cells using a mouse antibody for immunoprecipitation (IP) followed by western blot (WB) with rabbit antibodies to avoid antibody cross-reaction. In the course of these experiments, we noticed that in addition to a 210 kDa band corresponding to full-length TRPM7, several lower-molecular-weight bands were consistently detected (Figure 1A) . This finding suggested that the endogenous TRPM7 molecule is proteolytically cleaved at specific sites. We refer to these fragments as TRPM7-cleaved kinases (M7CKs). Because both antibodies recognize the TRPM7 C terminus, the major bands corresponded to TRPM7 fragments that were cleaved between the transmembrane and kinase domains. These fragments were not the result of proteolysis during IP because their relative abundance did not vary with time over 2-17 hr (Figure S1A available online) . It is unlikely that these bands belong to proteins unrelated to TRPM7, because they were sequentially recognized with two different TRPM7 antibodies used for IP and WB. Yet, to rule out this possibility, we stably expressed C-terminally hemagglutinin (HA)-tagged TRPM7 and used the well-characterized anti-HA-tag antibody (aHA) for IP and WB. Figure 1A shows that the ectopically expressed TRPM7-HA yielded major fragments identical to those for endogenous TRPM7 as well as a few minor lower-molecular-weight fragments that may have resulted from elevated protein expression. Because TRPM7-HA was ectopically expressed, this result obviates the possibility that C-terminal TRPM7 fragments were products of alternative RNA splicing. The fragments could have been generated from M7CK translation from multiple internal ribosome entry sites (IRESs) present on its C terminus or specific posttranslational proteolytic cleavage. However, IRES-dependent translation is unlikely, because among more then 100 eukaryotic cellular mRNAs proposed to contain IRESs, few have putative IRES sequences within exons (Thompson, 2012 ; see also http:// iresite.org). Moreover, there were no confirmed multiple IRESs within one mRNA. Thus, it is most likely that a proteolytic mechanism underlies the C-terminal fragment formation, as we previously demonstrated for caspase-mediated TRPM7 cleavage (Desai et al., 2012) . Thus, a substantial fraction of TRPM7 is cleaved in specific positions of the TRPM7 C terminus, liberating the protein kinase from the channel domain.
Different cell types display specific TRPM7 cleavage patterns seen as differences in relative expression of major fragments and generation of unique fragments ( Figure 1B ). This suggests there are cell-type-specific mechanisms defining the cleavage site and potentially distinct functions for each cleaved fragment. This hypothesis is consistent with the observation that the TRPM7 cleavage pattern changes during differentiation of mouse embryonic stem cells (mESCs) into specific progenitors ( Figure S1 ). Upon differentiation into embryoid bodies, distinct C-terminal cleaved fragments transiently appeared on days 8-12 of differentiation ( Figure S1B ). Neuronal progenitors derived from mESCs lack the 65 kDa C-terminal fragment detected in mESCs and display only full-length TRPM7 protein ( Figure S1C ). Animal tissues also display a diversity of TRPM7 cleavage patterns (Figure 1C ) more complex than those observed in cell lines, presumably because each tissue is composed of many cell types. Because a substantial proportion of TRPM7 protein was found as C-terminal fragments in many different cell types (e.g., 50%-70% in SV40 mes13 cells and close to 100% in mouse kidney), we expected to find equivalent amounts of the truncated channel. Thus, we immunoprecipitated TRPM7 with antibody recognizing the N-terminal epitope (NFP, amino acids 532-620) and western blotted with a C-terminal antibody (aCFP, amino acids 1,277-1,380) recognizing an epitope situated upstream of the C-terminal cleavage sites. This antibody combination reliably recognized transiently expressed recombinant full-length or truncated TRPM7 as well as endogenous full-length protein but failed to detect endogenous truncated channels ( Figure S1D ). The lack of channel-domain-containing protein suggests that the truncated channel was eliminated after C-terminal cleavage. This is consistent with results obtained using genetically modified mESCs that produce a TRPM7 RNA with the stop codon placed in front of kinase domain (halting translation after amino acid 1,537; Ryazanova et al., 2010) . Patch-clamp measurements of these cells failed to detect the characteristic TRPM7 current (Ryazanova et al., 2010) . Our antibody combination readily detected the full-length channel in WT mESCs and the caspasecleaved endogenous channel (Desai et al., 2012) , but not the truncated channel, in D-kinase mESCs ( Figure S1E ). These data suggest that C-terminally truncated TRPM7 protein containing the channel domain is normally eliminated from proliferating cells.
M7CK Binds Multiple Components of ChromatinRemodeling Complexes
In previous experiments (Krapivinsky et al., 2006) , we identified proteins that interact with TRPM7 using yeast two-hybrid screening. Evolutionarily conserved protein fragments of the human TRPM7 N-and C-terminal cytoplasmic domains were chosen as baits. Screening of a human brain library with a bait containing a portion of the TRPM7 C terminus (amino acids 1,364-1,865 of NP_060142.3) revealed the Ring1 and YY1 binding protein, RYBP (NP_036366.3), as a potential TRPM7 interactor. Because RYBP is a transcription factor strictly confined to the nucleus (García et al., 1999) and the TRPM7 channel is a plasma membrane and vesicular protein, we assumed that it was a false positive. However, when we performed tandem affinity purification of the same TRPM7 fragment stably expressed in SV40 mes13 cells, we identified a number of nuclear proteins that copurified with TRPM7 (see Table S1 ). Given that portions of the TRPM7 C terminus are naturally cleaved from the channel and located in the nucleus (shown in Figure 3 ), we set out to investigate these potential interactions.
In order to verify endogenous M7CK-interacting proteins, we generated mESCs lacking TrpM7 (TrpM7 À/À ; see Experimental
Procedures, Figure 1B , and Figure S2 ) and used these cells as negative controls in coimmunoprecipitation experiments. TRPM7 IP from mESCs confirmed binding of endogenous TRPM7 with the nuclear proteins RYBP, Ruvbl1/pontin, Ruvbl2/reptin, DDX3X, DDB1, and DBC1 ( Figure 2A ; Figure S3 ), all constituents of chromatin-remodeling complexes (see Table  S2 for annotation of these proteins). RYBP is a component of Polycomb repressor complex 1 (PRC1) and also interacts with the transcription factor YY1 (García et al., 1999; Tavares et al., 2012) . YY1 is part of the PRC2 histone methylation complex (Satijn et al., 2001 ) and the INO80 chromatin-remodeling complex (Cai et al., 2007; Wu et al., 2007) . The RNA helicase DDX3X and the DNA helicases pontin and reptin are also components of the INO80 complex (Vella et al., 2012; Huen et al., 2010) and of the histone deacetylase (Gallant, 2007) and b-catenin (Bauer et al., 2000; Kim et al., 2005; Sierra et al., 2006) complexes. DDB1 is the core component of the Cul4 ubiquitin ligase complex participating in DNA-damage-activated chromatin modification (Higa et al., 2006; Iovine et al., 2011) . Finally, DBC1 is an inhibitor of the histone deacetylases Sirt1 (Zhao et al., 2008) and HDAC3 (Chini et al., 2010) . Figure 2A and Figure S3B show that endogenous TRPM7 specifically binds core PRC1 protein RNF2, core PRC2 proteins Ezh2 and EED1, INO80 DNA helicase, YY1, b-catenin, and DDB1, but not HDAC1.
To verify that M7CK fragments of TRPM7 bind all these molecules, we made constructs expressing portions of the TRPM7 C terminus. Because we do not know the precise cleavage sites for endogenous TRPM7, we made a series of constructs that would express fragments of the C terminus with molecular masses close to those of major M7CKs, as calculated from their electrophoretic mobilities. Proteins containing mouse TRPM7 amino acids 1,299-1,863, 1,397-1,863, and 1,445-1,863 (all three contain the full kinase domain) most precisely comigrate with endogenous cleaved TRPM7 kinase ( Figure S3A ). We refer to these proteins as M7CK-Long, M7CK-Medium, and M7CK-Short, respectively. We tagged these proteins on their C termini with an HA epitope tag and tested their ability to bind TRPM7-interacting proteins. Figure 2B shows that proteins that bound endogenous TRPM7 are specifically coimmunoprecipitated with M7CKs when coexpressed in 293T cells (see also Figures S3B-S3E demonstrating binding of M7CK to Cul4, DBC1, and Sirt1). This result indicates that the binding site for the nuclear proteins is located on the M7CK portion of TRPM7's C terminus. Note that there are differences in the binding of nuclear proteins to the cleaved kinases; Ezh2 and YY1 bind all three cleaved kinases, while RYBP, EED, RNF2, and DDX3X do not bind M7CK-S. RING1A binds only M7CK-M, and INO80 binds only M7CK-L. This pattern of selective binding may rationalize the existence of multiple M7CKs in different cell types ( Figure 1B) .
To test for direct M7CK binding to interacting molecules, we affinity-purified HA-tagged M7CK-L produced in E. coli (Figure S3F) . Purified M7CK was combined with purified recombinant YY1 or the Ezh2-EED-Suz12 complex and pulled down with aHA agarose. As shown on Coomassie-stained gels (Figure 2C) , both YY1 and the Ezh2 complex specifically bound M7CK. The TRPM7-binding domain of RYBP (amino acids 22-47, zinc-finger domain) expressed as a glutathione S-transferase (GST) fusion protein and purified from E. coli directly bound purified M7CK-L ( Figure 2C ). In summary, TRPM7's cleaved kinase fragments directly bind several components of the chromatin-remodeling complexes PRC1, PRC2, and INO80.
Nuclear Location of M7CK Strikingly, abundant ectopically expressed TRPM7 C-terminal fragments were found in cell nuclei (Figure 3) . Analysis of the TRPM7 amino acid sequences (http://nls-mapper.iab.keio.ac. jp/cgi-bin/NLS_Mapper_form.cgi) predicted a putative nuclear localization signal on the kinase C terminus (mTRPM7 amino acids 1,780-1,807) that may provide the basis for importin-mediated M7CK nuclear localization. Additionally, nuclear proteins bound to M7CK could facilitate its translocation from cytosol to nucleus or retain M7CK in the nucleus; both mechanisms would increase nuclear M7CK. To determine whether M7CK-binding nuclear proteins affect M7CK nuclear abundance, cells were cotransfected with HA-tagged M7CK-and FLAG-tagged nuclear binding proteins (RYBP or RNF2) or empty vector as control. After cell fixation and immunostaining, relative nuclear and cytosolic M7CK was quantified in confocal images. As shown in Figure 3B , M7CK coexpression with nuclear-localized interactors substantially increased the relative nuclear concentration of M7CKs. 
Regulation of M7CK Binding
The preceding experiment suggests that M7CKs can be targeted to a particular nuclear protein by cleavage at a specific C-terminal site ( Figure 2B ). One obvious possibility is that TRPM7's channel activity regulates M7CK's cleavage from the channel domain. We compared the cleavage pattern of expressed WT TRPM7 and a nonconducting pore mutant that acts as a dominant negative (inhibits the conductance of the native channel; Krapivinsky et al., 2006) . Figure S4 shows that the cleavage pattern and extent of cleavage were identical. These data suggest that the TRPM7 C-terminal cleavage did not depend on a functional, ion-conducting pore. This implies that ions entering via the channel pore are not required to activate, for example, a localized protease that cleaves TRPM7's channel domain from its C-terminal-containing kinase domain.
Another simple hypothesis is that TRPM7's kinase ''tags'' itself via autophosphorylation for nuclear targeting. We thus tested whether M7CK's kinase activity is required for nuclear protein binding. Point mutations in TRPM7's kinase ATP-binding site (K1646A) eliminated kinase activity as detected by TRPM7 autophosphorylation (kinase-dead; Matsushita et al., 2005; Figure S3G ). These mutations had ambiguous effects on the binding of target molecules. The kinase-dead mutations did not affect Ezh2 binding but attenuated YY1 and RYBP binding and enhanced RNF2 binding ( Figure S3H ). Thus, regulation of TRPM7 kinase activity is a potential mechanism for targeting M7CK to different nuclear complexes. (Figures 4A and 4B ).
The critical role of the zinc-finger structure in binding of specific proteins to M7CK is supported by the finding that the 26-aminoacid RYBP sequence comprising the zinc-finger domain is sufficient for M7CK binding ( Figure 3C ). Half-maximal binding of RYBP, YY1, and RNF2, as well as the purified zinc-finger domain of RYBP to [Zn 2+ ], was $4 nM ( Figure 4C ), a concentration that is $5-to 10-fold higher than resting cytosolic [Zn 2+ ] (Krezel and Maret, 2006; Li and Maret, 2009; Taki et al., 2004; Vinkenborg et al., 2009 ). These levels would easily be reached by opening of TRPM7 channels, because the driving force for zinc is inward over the physiological range of voltages (E Zn $+80 mV). Thus, we set out to determine if TRPM7 Zn 2+ conduc- ] was normal in 
TrpM7
À/À cells; Figure S5 ). Importantly, knockout of TrpM7 resulted in the loss of the subpopulation of cells with substantially higher [Zn 2+ ] ( Figure 5E ). This suggests that TRPM7-channel activity was sufficient in these cells to elevate cytosolic zinc to levels that enabled targeting of M7CK to chromatin-remodeling complexes.
M7CK Phosphorylate Histones
Because M7CKs are functional kinases (Ryazanova et al., 2004) , we tested whether M7CK binding partners are substrates for M7CKs. However, extensive experiments failed to show direct phosphorylation of the verified interactors RYBP, YY1, EZH2, RING1A, Ruvbl2, and Cul4b by the kinase when the two proteins were bound (data not shown).
Many chromatin-remodeling complexes covalently modify core histones by lysine methylation, acetylation, ubiquitination, or sumoylation (Badeaux and Shi, 2013; Strahl and Allis, 2000) . These modifications are believed to alter chromatin structure by affecting the recruitment of nonhistone proteins that modulate genomic DNA accessibility for replication, repair, and ''tuning'' gene expression. Histones are also phosphorylated by several protein kinases; phosphorylation of specific histone residues has been associated with transcriptional regulation, apoptosis, cell-cycle progression, DNA repair, chromosome condensation, and developmental gene regulation (Baek, 2011; Sawicka and Seiser, 2012) and may constitute a histone code that underlies epigenetic inheritance (Cheung et al., 2000a) . The observation that M7CK is a functional protein kinase bound to several chromatin-remodeling complexes and located in the nucleus motivated us to explore whether M7CK modifies the phosphorylation state of established histone substrates for signaling kinases (Baek, 2011) . Figure 6A shows that global phosphorylation of histone H3 at serine 10 (H3S10p), serine 28 (H3S28p), and threonine 3 (H3T3p) is dramatically suppressed in TrpM7 À/À mESCs compared to WT cells. In contrast, phosphorylation of threonine 11 (H3T11p) was not affected and served as an intrinsic control. Differences in histone phosphorylation did not result from cell clonality, because different clones with the same genotype had identical levels of histone phosphorylation ( Figure 6A ). H3S10p and H3S28p levels were indistinguishable in WT3 cells grown in normal media or media with an additional 10 mM MgCl 2 that was required for growth of TrpM7 À/À mESCs (not shown).
To test whether TRPM7 kinase activity underlies changes in histone phosphorylation, we generated TrpM7 À/À mESCs stably expressing WT M7CK-L (KO9-CKa) and its kinase-dead mutant (KO9-CKi; see Figures S2F and S3G and Experimental Procedures for a description of these stable cell lines). Figure 6B shows that the expression of active kinase rescues changes in H3 histone phosphorylation, implying that the TRPM7 kinase is responsible. To our surprise, expression of the inactive M7CK mutant that was intended to serve as a negative control resulted in a further 4-to 6-fold decrease in phosphorylation of H3S10 and H3S27 ( Figure 6B ). This suggests that inactive M7CK acts as a dominant-negative regulator of another kinase (likely TRPM6 kinase because of its high sequence homology to TRPM7). H3 histone acetylation at lysines 9 and 27 activates multiple genes (Eberharter and Becker, 2002) . Synergistic coupling between H3S10 and H3S28 phosphorylation and acetylation of the adjacent K9 and K27 residues has been proposed (Cheung et al., 2000b; Lau and Cheung, 2011) . In agreement with this finding, TrpM7 À/À cells also display a substantial decrease in H3K9 and H3K27 acetylation ( Figure 6C ). We also measured a substantial increase of global trimethylation of H3K9 and H3K27 in TRPM7 À/À mESCs. It has been surmised that H3K9me3 and H3K27me3 antibodies poorly recognize their epitopes when the adjacent residue is phosphorylated (Duan et al., 2008, Lau and Cheung, 2011) . Indeed, when we pretreated cell lysates with l phosphatase, levels of the H3K9me3 and H3K27me3 were indistinguishable in WT and TRPM7 À/À mESCs (not shown). The loss of TRPM7 also resulted in a 6-to 8-fold increase in global phosphorylation of histone H2AX at serine 139 (gH2AX) that returns to normal upon expression of active M7CK ( Figure 6D ). Inactive kinase expression exhibits the same pattern as the H3 histone: it enhances the effect of the TRPM7 deletion, dramatically increasing gH2AX ( Figure 6F ). The TRPM7 kinase-dependent modulation of H2AX phosphorylation may be mediated by another protein kinase. Ablation of the TRPM7 kinase increased H2AX phosphorylation, while active M7CK expression caused a decrease in hyperphosphorylated gH2AX. On the other hand, global dephosphorylation of H3S10, H3T11, and H3S28, rescued by M7CK expression, is consistent with direct phosphorylation of H3 by M7CK. Because the TRPM7 C-terminal antibody specifically coimmunoprecipitates H3 histone, but not H2AX histone, from nuclear extracts of mESCs ( Figure 6G ), M7CK tightly binds H3, but not H2AX. In addition, purified M7CK phosphorylated purified recombinant histones H2, H3, and H4 in vitro (shown by 33 P incorporation; Figure 6H ). As shown by western blot with phosphospecific antibody, purified M7CK phosphorylates purified H3 histone at S10 and S28 ( Figure 6I ). These results imply that M7CK directly phosphorylates selected histone residues.
M7CK-Dependent Histone Phosphorylation Correlates with Gene Expression
Histone phosphorylation acts as a critical intermediate step in chromosome condensation during cell division, DNA-damage repair, and transcriptional regulation (Baek, 2011; Banerjee and Chakravarti, 2011; Berger, 2010) . Phosphorylation of histone H2AX on Ser139 in mammalian cells is one of the early responses to double-strand DNA breaks (Xu and Price, 2011) , motivating us to test whether a global increase in gH2AX reflects increased DNA damage in TrpM7 Global increases of H3S10p and H3S28p in mitotic cells demonstrate temporal and spatial associations with chromosome condensation (Goto et al., 2002; Wei et al., 1999) and are sufficiently reliable that H3S10p is widely used as a mitotic marker. If H310p and H3S28p dephosphorylation in TrpM7 À/À cells reflects a state of mitotic histone phosphorylation, it would be detected as a decrease in the proportion of mitotic cells. No decrease in the percentage of mitotic cell phosphohistone immunofluorescence ( Figure S6B ) was observed in counts of H310p and H3S28p immunofluorescence-positive WT and TrpM7 À/À cells. Thus, M7CK phosphorylates histones in interphase. Our results suggest that TRPM7 kinase has no major effect on the cell cycle, consistent with its lack of effect on cell-proliferation rates ( Figure S2 ). Accumulating evidence suggests that local histone phosphorylation on specific residues, particularly H3S10, affects the expression of specific genes (Baek, 2011; Berger, 2010; Yang et al., 2012) . We next determined if M7CK activity affected gene expression and if specific gene expression correlated with M7CK-dependent histone phosphorylation of the affected genes. We performed microarray analysis for differential gene expression in WT and TrpM7 À/À mESCs (Table S3 ). For further validation of the microarray data, we selected several genes with maximally downregulated expression levels in TrpM7 confirmed the microarray data and demonstrated that gene downregulation in TrpM7 À/À cells was rescued by M7CK expression ( Figure 7A ). This result argues that gene regulation was TRPM7 kinase dependent. Chromatin immunoprecipitation (ChIP) with antibody specifically recognizing phosphorylated H3S10 followed by qPCR with primers amplifying proximal promoter sequences of the same genes (ChIP-qPCR) showed that H3S10p content in promoters of the genes tested was substantially decreased in TrpM7 À/À cells and that this decrease was rescued by M7CK expression ( Figure 7B ). These results suggest that M7CK-mediated phosphorylation of H3S10 regulates gene expression.
DISCUSSION
Here, we showed that a portion of TRPM7's C terminus containing the functional kinase is cleaved from the channel moiety and accumulates in the nucleus by binding to transcription factors composing chromatin-remodeling complexes. In the nucleus, M7CK phosphorylates histones on specific residues involved in essential cellular functions such as transcription regulation, DNA repair, and mitotic chromatin condensation. We also demonstrated that TRPM7 increases cytosolic free [Zn 2+ ] and that binding of zinc-finger-containing M7CK interactors is zinc dependent. These findings suggest a signaling mechanism in which TRPM7 activation increases cytosolic [Zn 2+ ], that in turn stimulates binding of M7CK to zinc-dependent transcription factors. M7CK translocation to the nucleus and subsequent phosphorylation of nuclear histones changes the chromatin covalent modification landscape affecting cell differentiation and embryonic development. The linkage of protein kinase and channel domains in the evolution of TRPM channels suggests that these functions are coupled. We propose that this function is to link zinc entry and chromatin-modifying functions, in particular through the zinc dependence of M7CK binding to particular nuclear proteins. Because zinc concentrations that enable M7CK binding (EC 50 = 4 nM) are only 5-to 10-fold higher then resting intra- M7CK formation depends on cell lineage, conditions, and time, suggesting that specific M7CKs are made in the course of development and cell differentiation. Whether this mechanism is based on cell-specific activation/expression of selective proteases or the presence of specific proteins protecting the cleavage sites is not known. Interestingly, after truncation, the portion of TRPM7 containing the channel domain is eliminated. One potential rationalization for this observation may be that the kinase-deleted channel stimulates apoptosis (Desai et al., 2012) . That the channel is deleted after kinase cleavage suggests that the channel is required for kinase function, not vice versa.
Chromatin-remodeling complexes, and particularly Polycomb complexes, are transcriptional modifiers that regulate a number of key processes in cell differentiation via covalent histone modifications (Fisher and Fisher, 2011; Surface et al., 2010) . M7CKs interact with several transcription factors and nuclear proteins composing chromatin-modifying complexes. We found several potential regulatory mechanisms that may tune the specificity of M7CK binding to particular nuclear complexes. M7CK binding to different interactors depends on the cleavage site, ]. The combination of these factors may provide specific, cell-context-dependent M7CK nuclear complex formation. Although logical to assume that M7CK binding partners were potential substrates for the M7 kinase, our in vitro experiments failed to show direct M7CK phosphorylation of RYBP, YY1, EZH2, RING1A, Ruvbl2, or Cul4b when they were in complex with M7CK. We cannot exclude, however, the possibility that some other M7CK binding partners are phosphorylated. Nevertheless, M7CK activity is important for nuclear protein binding, perhaps because M7CK autophosphorylation (Clark et al., 2008b ) is critical for these interactions. In summary, our findings demonstrate that nuclear protein binding to M7CK increases nuclear concentrations of M7CK where it phosphorylates histones, indicating that these proteins retain M7CKs in nucleus. These results strongly suggest that M7CK association with transcription factors may help target M7CK to a specific genomic location to provide site-specific histone phosphorylation.
Association of M7CK with subunits of PRC2 may seem at odds with the existing paradigm that PRC2-dependent H3K27 methylation and PRC2 binding to promoters represses transcriptional activity while H3S28 phosphorylation facilitates H3K27 acetylation and transcriptional activation. However, recent findings indicate that PRC2 (Jacob et al., 2011) and the Ezh2 methyltransferase subunit can also activate transcription (Simon and Kingston, 2013) . In particular, H3K27me3 and H3S28p can coexist on the same histone molecule, and H3K27me3S28 phosphorylation displaces PRC2 from the promoter (Gehani et al., 2010) . In a similar scenario, M7CK binding of PRC2 may target it to a specific site where it phosphorylates the critical H3S28 and displaces PRC2 to activate transcription.
We identified two modes of TRPM7-dependent histone phosphorylation. Phosphorylation of histone H3 residues was dramatically attenuated when TrpM7 was genetically silenced but increased when M7CK was restored in TrpM7 À/À cells. In conjunction with experiments demonstrating tight binding of M7CK to H3 histone and in vitro H3 phosphorylation by M7CK, these data strongly suggest that M7CK directly phosphorylates H3 histone in vivo. A second mode of TRPM7-dependent histone phosphorylation was observed as a substantial increase of histone H2AX-Ser139 phosphorylation in TrpM7 À/À cells that was restored to WT levels by M7CK. This indirect action suggests that ATM, ATR, and DNA-PK, the protein kinases known to phosphorylate H2AX (Banerjee and Chakravarti, 2011) , may be targets of M7CK. In summary, the chanzyme TRPM7 is cleaved in a cell-and time-specific fashion. The cleaved fragment, containing kinase domain and upstream intrinsically disordered region, binds to chromatin-remodeling complex proteins in a Zn 2+ -dependent fashion. In the nucleus, the kinase phosphorylates histones on specific residues known to be functionally important for cell differentiation and embryonic development.
EXPERIMENTAL PROCEDURES
Full details are provided in Extended Experimental Procedures. Mice were treated in accordance with guidelines approved by the Boston Children's Hospital (BCH) animal care and use committee.
cDNA Constructs HA-and FLAG-tagged M7CK constructs were made by cloning PCR-amplified mouse TrpM7 sequences into modified phCMV3 (Genlantis) and further subcloning of tagged cDNA into a pPyCAG-IP vector (from Ian Chambers, University of Edinburgh; Chambers et al., 2003) or the modified bacterial expression vector pET32 (Novagen) containing an N-terminal fusion of 10xHis-GB1 sequence (from Martin Kurtev, BCH). The NTAP vector, made in a pcDNA4TO backbone (Invitrogen), contained a sequence encoding Protein G, a tobacco etch virus protease cleavage site, and streptavidin-binding peptide, followed by a multiple cloning site, IRES, and EGFP (Bü rckstü mmer et al., 2006). NTAP-M7CK cDNA was made by in-frame subcloning of the mouse TrpM7 sequence encoding amino acids 1,364-1,863 and C-terminal HA tag into the NTAP vector.
Derivation and Culture of mESCs Blastocysts were isolated from TrpM7
+/À mice (Jin et al., 2008) 3.5 days postcoitum and cultured on a layer of g-irradiated mouse embryonic fibroblasts using standard procedures (Bryja et al., 2006) in media containing an additional 10 mM MgCl 2 . Single embryonic stem cell colonies were expanded, genotyped, and transfected with linearized cDNA using nucleofection embryonic stem cell solution (protocol A-23; Lonza); stably transfected cells were selected by antibiotic incubation.
Biochemical Procedures
See Extended Experimental Procedures for details regarding cell extracts for tandem affinity purification, TRPM7 IP, histone western blots, antibodies, and buffers. NTAP-M7CK was purified as described in (Bü rckstü mmer et al., 2006) in lysis buffer; purified proteins were separated on SDS-PAGE and proteins digested with trypsin. MALDI-TOF MS and MS/MS peptide analyses were carried out (Krapivinsky et al., 2011) in the proteomic core facility at BCH. Purified histones (New England Biolabs) were phosphorylated in vitro with purified M7CK-L in buffer containing [g-33 P]-ATP. GST-RYBP protein was purified from expressing BL21 bacteria using glutathione Sepharose (GE Healthcare). M7CK-L mouse TRPM7 protein containing N-terminal 10xHis-GB1 (Hammarströ m et al., 2002) and C-terminal HA-epitope tag was purified from lysates of BL21 bacteria expressing the protein on a cobalt resin (Talon, Clontech). Samples run on different gels are combined in figures and aligned against identical molecular weight markers (Figures 1, 2, 4 , 6, S1, S3, and S4) as indicated by blank spaces between lanes. the ratio of fluorescence of Mag-Fura-2 at 380 nm in nominally free and saturating [Mg 2+ ]. Mag-Fura K D for Mg 2+ = 1.5 mM (Raju et al., 1989) .
Microarray expression profiling was performed on Illumina MouseWG-6 v2.0 Expression BeadChip arrays at the BCH microarray facility using GenomeStudio software. These data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE55578 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE55578). 
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